09-03-2021 10:44 AM | Source: Religare Broking Ltd
Buy Alembic Pharmaceuticals Ltd Target Rs.815 - Religare Broking
Religare Super Idea
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer http://ex.religareonline.com/disclaimer
SEBI Registration number is INZ000174330
Above views are of the author and not of the website kindly read disclaimer
Latest News
Nail Fashion Trends: The Art of Expressing Style Thr...
Sustainable Living: Tips for a Greener Lifestyle
PM Narendra Modi to attend Christmas celebrations ho...
Government launching 3 apps to protect consumers in ...
Kia to launch compact SUV `Syros` in India next year
GST recommendations to create business-friendly envi...
CII seeks priority sector lending for new and emergi...
The Wealth of Experiences: How Travel and Cultural E...
India`s tax panel rejects airlines` call to add avia...
Rozgar Mela: PM Narendra Modi to distribute 71,000 a...
Tag News
India's MedPlus Health posts two-fold surge in Q4 profit on strong sales
Alembic Pharmaceuticals surges on getting EIR for Solid Oral Formulation Facility at Vadodara
Alembic Pharmaceuticals gains on completing ANVISA GMP audit at API-III Facility without any observations
Alembic Pharmaceuticals trades higher on completing USFDA`s inspection at Derma Facility without any observations